EFFICIENCY OF COMBINATION THERAPY WITH ROSUVASTATIN FOR ACUTE CORONARY SYNDROME AND IN THE INFARCTION PERIOD
- Authors: Islamova S.1, Babushkina G.1
-
Affiliations:
- City Clinical Hospital Thirteen
- Issue: Vol 26, No 12 (2015)
- Pages: 68-69
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116457
- ID: 116457
Cite item
Abstract
The paper shows the efficiency of using different rosuvastatin doses in the combination therapy of patients with acute coronary syndrome and in the postinfarction period according to lipidogram readings and intracardiac hemodynamic parameters.
Full Text
About the authors
S. Islamova
City Clinical Hospital Thirteen
Email: svetlana-islamov@mail.ru
G. Babushkina
City Clinical Hospital Thirteen
References
- Ройтберг Г.Е., Струтынский А.В. Внутренние болезни. Сердечнососудистая система: учеб. пособие. 3-е издание / М.: МЕДпресс-информ, 2013; с. 495.
- Джаиани Н.А. Применение статинов при остром коронарном синдроме. Позиции розувастатина // Рус. мед. журн. - 2014; 18: 1345-8.
- Hamm C., Bassand J., Agewall S. еt al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) // Eur. Heart J. - 2011; 32: 2999-3054.
- Erbs S., Beck E., Linke A. et al. High-dose rosuvastatin in chronic heart failure promotes vas-culogenesis, corrects endothelial function, and improves cardiac remodeling-results from a randomized, double-blind, and placebo-controlled study // Int. J. Cardiol. - 2011; 146 (1): 58-63.
- Pitt B., Loscalzo J., Monyak J. et al. Comparison of Lipid-Modifying Efficacy of Rosuvastatin Versus Atorvastatin in Patient With Acute Coronary Syndrome (from the LUNAR) // Am. J. Cardiol. - 2012; 109 (9): 1239-46.